{"log_id": 5905432203380988364, "direction": 0, "words_result_num": 49, "words_result": [{"probability": {"variance": 0.00312, "average": 0.968027, "min": 0.821522}, "location": {"width": 283, "top": 186, "height": 27, "left": 144}, "words": "对驾驶机动车和操纵机器能力的影响"}, {"probability": {"variance": 0.015435, "average": 0.956637, "min": 0.398232}, "location": {"width": 532, "top": 213, "height": 28, "left": 145}, "words": "雷奈酸对驾驶机动车和操作机器能力没有影响或影响可以忽略不计"}, {"probability": {"variance": 0.000153, "average": 0.988218, "min": 0.959671}, "location": {"width": 226, "top": 249, "height": 30, "left": 141}, "words": "[孕妇及哺乳期妇女用药]"}, {"probability": {"variance": 0.001321, "average": 0.94817, "min": 0.911827}, "location": {"width": 39, "top": 285, "height": 20, "left": 146}, "words": "妊娠"}, {"probability": {"variance": 0.013784, "average": 0.948547, "min": 0.399801}, "location": {"width": 496, "top": 310, "height": 26, "left": 148}, "words": "本品仅用于绝经后妇女。没有关于奈酸用于妊娠妇女的资料"}, {"probability": {"variance": 0.013242, "average": 0.947495, "min": 0.426462}, "location": {"width": 971, "top": 338, "height": 28, "left": 148}, "words": "在动物试验中,妊娠期使用大剂量露奈酸治疗大鼠和兔子的下一代中观察到可逆性的骨作用(详见毒理研究)如果本品在妊"}, {"probability": {"variance": 0.001163, "average": 0.980685, "min": 0.881476}, "location": {"width": 251, "top": 372, "height": 23, "left": 145}, "words": "娠期无意中服用,必须立即停药"}, {"probability": {"variance": 0, "average": 0.998985, "min": 0.998711}, "location": {"width": 35, "top": 404, "height": 21, "left": 146}, "words": "哺乳"}, {"probability": {"variance": 0.020615, "average": 0.937792, "min": 0.351199}, "location": {"width": 539, "top": 430, "height": 25, "left": 145}, "words": "理化数据显示酸可以分泌至乳汁中。哺乳期妇女禁用奈酸"}, {"probability": {"variance": 0.008511, "average": 0.90673, "min": 0.814477}, "location": {"width": 41, "top": 463, "height": 25, "left": 144}, "words": "生育"}, {"probability": {"variance": 0.005301, "average": 0.97, "min": 0.663994}, "location": {"width": 448, "top": 492, "height": 26, "left": 146}, "words": "在动物研究中未观察到对雄性和雌性动物生育能力的影响"}, {"probability": {"variance": 0.008041, "average": 0.945891, "min": 0.767909}, "location": {"width": 94, "top": 528, "height": 25, "left": 152}, "words": "儿童用药]"}, {"probability": {"variance": 0.013703, "average": 0.946787, "min": 0.550287}, "location": {"width": 708, "top": 556, "height": 29, "left": 145}, "words": "由于缺乏在儿童和青少年(18岁以下)中的安全性和有效性数据,不建议这一年龄组使用本品"}, {"probability": {"variance": 0.000162, "average": 0.987684, "min": 0.966105}, "location": {"width": 104, "top": 595, "height": 27, "left": 143}, "words": "老年用药"}, {"probability": {"variance": 0.005006, "average": 0.953336, "min": 0.780227}, "location": {"width": 272, "top": 627, "height": 24, "left": 146}, "words": "参见【用法用量]及[药代动力学"}, {"probability": {"variance": 6e-06, "average": 0.997966, "min": 0.992922}, "location": {"width": 125, "top": 662, "height": 27, "left": 154}, "words": "药物相互作用"}, {"probability": {"variance": 0.001201, "average": 0.805917, "min": 0.771266}, "location": {"width": 64, "top": 659, "height": 33, "left": 896}, "words": "8\\"}, {"probability": {"variance": 0.017338, "average": 0.925713, "min": 0.405425}, "location": {"width": 969, "top": 688, "height": 27, "left": 146}, "words": "食物、牛奶和牛奶制品,以及有钙的药品降低需奈酸铜生物利用度达60-70%。因此,服用本和上述合品或药品时当至"}, {"probability": {"variance": 0.01859, "average": 0.924106, "min": 0.461335}, "location": {"width": 277, "top": 720, "height": 26, "left": 146}, "words": "少问隔2小时(详见[药代动力学])"}, {"probability": {"variance": 0.013926, "average": 0.950647, "min": 0.50581}, "location": {"width": 969, "top": 744, "height": 31, "left": 146}, "words": "由于二价阳离子能够与口服的环素和喹诺鞘类抗生素在胃肠道形成复合物,从而减少它们的吸收,因此不推荐雷奈酸锶与这"}, {"probability": {"variance": 0.010216, "average": 0.9345, "min": 0.622906}, "location": {"width": 710, "top": 774, "height": 25, "left": 149}, "words": "些药品同时服用。为谨慎起见,在服用四环素成峰诺酮类抗生素时,应当暂时停用雷奈酸锶"}, {"probability": {"variance": 0.02059, "average": 0.941974, "min": 0.382776}, "location": {"width": 976, "top": 800, "height": 25, "left": 147}, "words": "药物相互作用的体内临床研究显示氢氧化铝和氢氧化镁在服用雷东酸锶之前2小时服用或与雷奈酸同时服用,雷奈酸的吸"}, {"probability": {"variance": 0.02017, "average": 0.937608, "min": 0.351978}, "location": {"width": 977, "top": 825, "height": 28, "left": 145}, "words": "收稍有降低(AUC降低20-25%),但是当在服用酸锶之后2小时服用抗酸剂,吸收几乎未受影响。因此最好在服用雷酸"}, {"probability": {"variance": 0.015138, "average": 0.929763, "min": 0.48861}, "location": {"width": 921, "top": 853, "height": 25, "left": 157}, "words": "2小时后再服用抗酸剂。但是:由于建议冒奈酸题前服用而使得所推荐服药方法不能实行时,同时服用仍然可以接受"}, {"probability": {"variance": 0.004373, "average": 0.973017, "min": 0.705912}, "location": {"width": 315, "top": 882, "height": 23, "left": 151}, "words": "未观察到与口服维生素D的药物相互作用"}, {"probability": {"variance": 0.01207, "average": 0.957373, "min": 0.360754}, "location": {"width": 958, "top": 904, "height": 26, "left": 148}, "words": "在临床研究中服用雷奈酸的目标入群在同时服用其他常用药物时,未发现临床药物相互作用的证据成血水平相应升高的据"}, {"probability": {"variance": 0.016214, "average": 0.929713, "min": 0.362475}, "location": {"width": 964, "top": 929, "height": 31, "left": 150}, "words": "包括:非鲁体类抗炎药物包括乙酰水杨酸),苯类如扑热息痛),阻带剂质子泵抑制剂,利尿剂,地高辛和强心类,治疗"}, {"probability": {"variance": 0.024033, "average": 0.92482, "min": 0.3757}, "location": {"width": 974, "top": 957, "height": 29, "left": 150}, "words": "心疾病的有机硝酸和其他血管扩张剂,钙通道阻滞剂,一断剂,ACE制剂,血管紧张素抗剂,选择性2肾上素能受"}, {"probability": {"variance": 0.01822, "average": 0.930891, "min": 0.49468}, "location": {"width": 682, "top": 986, "height": 25, "left": 147}, "words": "体激动剂,口服抗凝剂,血小板聚集抑制剂,他汀类药物,氯贝丁酯和苯二氮卓类衍生物"}, {"probability": {"variance": 0.012773, "average": 0.933207, "min": 0.737463}, "location": {"width": 85, "top": 1025, "height": 24, "left": 154}, "words": "药物过量"}, {"probability": {"variance": 0.015268, "average": 0.9458, "min": 0.442463}, "location": {"width": 975, "top": 1048, "height": 28, "left": 148}, "words": "健康绝经后妇女在一项临床研究中重复服用雷奈酸4克/日长达25日,显示出良好的耐受性,健康年轻男性志愿者单次服药"}, {"probability": {"variance": 0.019812, "average": 0.936693, "min": 0.416439}, "location": {"width": 269, "top": 1079, "height": 23, "left": 149}, "words": "剂高达11克,未导致特别的症状"}, {"probability": {"variance": 0.000349, "average": 0.989136, "min": 0.925842}, "location": {"width": 779, "top": 1101, "height": 29, "left": 150}, "words": "在临床研究中发生的药物过量情况(高达4克/日,最长持续时间为147日),未观察到相关的临床事件"}, {"probability": {"variance": 0.005592, "average": 0.974831, "min": 0.529717}, "location": {"width": 783, "top": 1128, "height": 28, "left": 147}, "words": "牛奶和抗酸剂有助于减少活性物质的吸收。当发生严重过量时,呕吐可能会排出尚未吸收的活性物质"}, {"probability": {"variance": 0.000687, "average": 0.980719, "min": 0.929052}, "location": {"width": 95, "top": 1167, "height": 25, "left": 146}, "words": "[临床试验"}, {"probability": {"variance": 8e-06, "average": 0.994385, "min": 0.991905}, "location": {"width": 61, "top": 1202, "height": 21, "left": 157}, "words": "床疗效"}, {"probability": {"variance": 0.014298, "average": 0.943357, "min": 0.470931}, "location": {"width": 974, "top": 1220, "height": 32, "left": 149}, "words": "骨质疏松症的定义是椎体成髋部的BMD低于正常年轻人峰值的平均值2.5SD或更多,与绝经后骨质疏松症有关的危险因素包"}, {"probability": {"variance": 0.009085, "average": 0.947939, "min": 0.500007}, "location": {"width": 954, "top": 1252, "height": 25, "left": 150}, "words": "括低骨、低骨密度、早绝经、吸烟史和骨质疏松症家族史,骨质疏松症的临床后果是骨折。随着危险因素的数量增加而增加"}, {"probability": {"variance": 0.000583, "average": 0.987341, "min": 0.923766}, "location": {"width": 195, "top": 1284, "height": 22, "left": 150}, "words": "绝经后骨质疏松症的治疗"}, {"probability": {"variance": 0.013175, "average": 0.946834, "min": 0.416997}, "location": {"width": 972, "top": 1306, "height": 29, "left": 151}, "words": "本品的抗骨折研究项目包括2项安惠剂对照的期临床研究:SOI究和 TROPOS研究。在SOT研究中,共有1649名诊断为背"}, {"probability": {"variance": 0.015163, "average": 0.943713, "min": 0.395515}, "location": {"width": 972, "top": 1333, "height": 28, "left": 150}, "words": "质疏松症(腰椎BMD降低和发生过体骨折的绝经妇女参加,平均年龄是70岁,在 TROPOS研究中,共有5091名绝经后骨质疏松"}, {"probability": {"variance": 0.019295, "average": 0.93008, "min": 0.394988}, "location": {"width": 971, "top": 1359, "height": 29, "left": 150}, "words": "妇女(降低的股骨颈BMD,半数以上发生过骨折)参加,平均年龄77岁,将SOT和 TROPOS合并在一起,在选时年龄超过80岁"}, {"probability": {"variance": 0.006916, "average": 0.957448, "min": 0.519509}, "location": {"width": 973, "top": 1386, "height": 29, "left": 149}, "words": "的患者共有1566名《占研究人群的23.1%)。在这些治疗的基础上(2克/日雷奈酸想或安慰剂),患者在2项研究的全过程中还服用了"}, {"probability": {"variance": 0.011305, "average": 0.954076, "min": 0.60301}, "location": {"width": 232, "top": 1418, "height": 23, "left": 149}, "words": "经调整的钙和维生素D补充剂"}, {"probability": {"variance": 0.010594, "average": 0.961255, "min": 0.40315}, "location": {"width": 974, "top": 1437, "height": 31, "left": 151}, "words": "在SO研究中,经过3年的治疗,本品降低新发生的体折的相对危险生达41%(详见表1)这种作用在治疗1年后就显著地"}, {"probability": {"variance": 0.009278, "average": 0.956201, "min": 0.528713}, "location": {"width": 970, "top": 1465, "height": 29, "left": 150}, "words": "表现出来。在入时已有过多处骨折的妇女被证明获得了相似的益处。而就临床准体骨折(定义为与背痛有关的骨折和/或身高至"}, {"probability": {"variance": 0.015927, "average": 0.946801, "min": 0.440631}, "location": {"width": 953, "top": 1493, "height": 27, "left": 151}, "words": "少降低1cm而论:相对危险降低了38%。与安慰剂相比:本品同减少了身高至少降低1cm的患者数。同样与安慰剂相比"}, {"probability": {"variance": 0.00974, "average": 0.946528, "min": 0.569379}, "location": {"width": 694, "top": 1520, "height": 25, "left": 152}, "words": " QUALIOS特殊量表的生活质量评价和SF-36普通量表的一般建康预测评分显示了本品的益处"}, {"probability": {"variance": 0.008717, "average": 0.969112, "min": 0.365826}, "location": {"width": 903, "top": 1545, "height": 31, "left": 151}, "words": "本品降低新发生的体骨折的危险性的疗效在 TROPOS研究中得到了证实,包括在治疗前没有性骨折的骨质疏松患者"}], "language": 3}